1YRSBIO-RAY BIOTECH. CO., LTD. PABP BRANCH

Aperçu de l'entreprise

Album de la société3

Informations de base
With over 35 years of experience in medical research and clinical work, our expertise lies in immunology and oncology. We adhere to the belief of seeking non-harmful remedies and strive to develop natural, safe, and effective healthcare methods. Our outstanding research achievements include inventing DNA vaccines for treating allergic diseases as early as 1996, publishing in the prestigious scientific journal "Nature Medicine," and establishing our reputation as an internationally renowned immunology expert. Throughout years of clinical work, we observed that current treatments for immune-related diseases mostly focus on symptom control without addressing the underlying immune system disorder. These treatments are like "band-aid solutions" that merely provide temporary relief. After dedicated research efforts, we successfully developed the first indigenous anti-allergic probiotic strain in Taiwan. Through rigorous scientific evidence from cell experiments, animal studies, and human trials, our product obtained international patents and certifications as a nationally recognized health food that assists in allergy management. Its success in the market ignited the probiotics trend in Taiwan, and even after more than a decade, its popularity remains strong, propelling the functional probiotics industry in Taiwan forward.
  • Transactions
    -
  • Temps de réponse
    ≤14h
  • Taux de réponse
    50%
Type d’entreprise
Fabricants
Pays / région
Taiwan, China
Produits principauxNombre d’employés total
51 - 100 People
Chiffre d’affaires total
Below US$1 Million
Année de création
2012
Certifications(3)Certifications de produits
-
Brevets
-
Marques
-
Principaux marchés

Capacité du produit

Information de l'usine

Taille de l’usine
3,000-5,000 square meters
Lieu de l’usine
No. 21-3, Shennong E. Rd., Changzhi Township, Pingtung County 90846, Taiwan (R.O.C.)
Nbre de lignes de production
3
Fabrication sous contrat
OEM Service Offered
Valeur de la production annuelle
Above US$100 Million